Effect of Whirlpool Therapy Combined With Botulinum Toxin in Children With Cerebral Palsy
Investigation of the Effects of Combining Whirlpool Therapy With Botulinum Toxin Treatment on Spasticity, Gait, and Motivation in Children With Cerebral Palsy
1 other identifier
interventional
43
1 country
1
Brief Summary
This study aims to investigate the effects of adding whirlpool therapy to standard rehabilitation in children with cerebral palsy who recently received botulinum toxin-A injections. Participants will be divided into two groups: one group will receive standard physiotherapy, while the other group will receive physiotherapy combined with whirlpool therapy. The effects of these interventions on spasticity, gait function, and motivation will be evaluated over a 12-week follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
CompletedFirst Submitted
Initial submission to the registry
June 13, 2026
CompletedFirst Posted
Study publicly available on registry
July 8, 2026
CompletedJuly 8, 2026
July 1, 2026
1.2 years
June 13, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gross Motor Function Measure-88 (GMFM-88) - Dimension E (Walking, Running and Jumping)
The primary outcome measure was the Gross Motor Function Measure-88 (GMFM-88) Dimension E, which evaluates walking, running, and jumping abilities in children with hemiplegic cerebral palsy. Each item is scored on a 4-point scale (0-3), and raw scores are converted to percentage values (0-100). Dimension E consists of 24 items, with a maximum raw score of 72 points.
Baseline (Week 0), Week 4 (post-treatment), Week 12 (follow-up)
Secondary Outcomes (6)
Modified Ashworth Scale (MAS)
Week 0, Week 4, Week 12
Pediatric Motivation Scale
Week 4, Week 12
DIERS 4D Motion Analysis System
Baseline (Week 0), Week 4, Week 12
10-Meter Walk Test (10MWT)
Baseline (Week 0), Week 4, Week 12
Gross Motor Function Measure-88 (GMFM-88) - Dimension D (Standing)
Baseline (Week 0), Week 4, Week 12
- +1 more secondary outcomes
Study Arms (2)
Botulinum Toxin + Conventional Physiotherapy + Whirlpool Therapy
EXPERIMENTALPatients receiving 4 weeks of conventional physical therapy combined with whirlpool therapy (20 minutes per session, 3 times per week).
Botulinum Toxin + Conventional Physiotherapy
ACTIVE COMPARATORPatients receiving 4 weeks of conventional physical therapy alone.
Interventions
Standard rehabilitation program including range of motion exercises, stretching, strengthening, balance, coordination, endurance, and gait training, 5 days per week for 4 weeks under physiotherapist supervision.
Whirlpool therapy administered 3 times per week for 4 weeks, 20 minutes per session (total 12 sessions), in addition to conventional rehabilitation.
Eligibility Criteria
You may qualify if:
- Diagnosis of hemiplegic cerebral palsy
- Age between 3 and 10 years
- Gross Motor Function Classification System (GMFCS) levels I-II
- Sufficient cognitive level to follow instructions
- Ability to walk at least 10 meters with an orthosis and/or walking aid
- Receipt of botulinum toxin injection to the lower extremity within the past week
- Ability to walk independently for 1 minute without orthosis or assistive device
You may not qualify if:
- Uncontrolled epilepsy
- Urinary incontinence
- Presence of lower extremity contractures
- History of previous orthopedic surgery
- Presence of hip subluxation
- Ataxic or dyskinetic cerebral palsy
- History of any botulinum toxin injection within the 6 months prior to the current 1-week post-injection period
- Inability to cooperate during clinical assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik City Hospital
Ankara, Ankara, 06010, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
DAMLA CANKURTARAN, MD
Ankara Etlik City Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors were blinded to group allocation. Participants and physiotherapists were not blinded due to the nature of the intervention. Group assignments were concealed from evaluators during all assessments and data analyses were performed using coded group labels.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician
Study Record Dates
First Submitted
June 13, 2026
First Posted
July 8, 2026
Study Start
February 1, 2025
Primary Completion
May 1, 2026
Study Completion
May 31, 2026
Last Updated
July 8, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share